But whoever bought yesterday made a very nice winning bet.
I-AM Capital Acquisition Company, which had originally scheduled its shareholder vote to approve its business combination with Smaaash Entertainment for today (October 4, 2018), is postponing the vote-date to a to-be-determined later date within the next 45 days.
However, there was some activity yesterday in the share and somebody made a very good bet…The lowest share price traded was $5.95…. and whoever bought anywhere near yesterday’s close price of $6.46 now gets a whole new record date! That means they can be eligible again to redeem for $10.21 per share in trust (and likely more than that now with interest). That’s a lotta yield. There’s wasn’t a ton of volume traded, but Christmas came early for whoever did buy.
Furthermore, even if the vote today was never cancelled, whoever still held the share going into the vote (and owned it as of the record date) would have likely ALSO had a good day, but here’s why: The press release implied there were going to be a lot of redemptions. That means the 600,000 share dividend would have been carved up for a very small number of shareholders left. So if you owned the share at $10.00, but post-vote there were so little shareholders left you got a dividend of one extra share, you would then own two shares at the current trading price of $6.46. Not too shabby.
I-AM Capital is now looking to take additional steps to shore up the transaction, including finding a backstop arrangement and that will most likely be done far below a $10.00 share price. Stay tuned to see what develops.
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...